2 results
Approved WMOCompleted
PrimaryObjectives: 1. Evaluate the efficacy of adding anacetrapib 100 mg for 52 weeks relative to placebo on plasma concentrations of LDL-C. 2. Evaluate the safety and tolerability of 52 weeks of treatment with anacetrapib 100 mg.Hypotheses: 1.…
Approved WMORecruiting
1. Effect evaluationTo assess the effectiveness of dynamic bracing on quality of life in patients suffering from an osteoporotic vertebral compression fracture (OVCF).2. Economic evaluationTo examine whether dynamic bracing compared to standard care…